Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Orphanet Journal of Rare Diseases|September 12, 2018
A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher diseaseMonica Hadi, Paul Swinburn, Luba Nalysnyk, et al.
BJU International|November 26, 2010
Preferences for antimuscarinic therapy for overactive bladderPaul Swinburn, Andrew Lloyd, Shehzad Ali, et al.
Journal of Child Neurology|July 17, 2023
Caregivers' Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative StudyJade Marshall, Hanna Skrobanski, Lisa Moore-Ramdin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 12, 2013
Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UKPaul Swinburn, Andrew Lloyd, K S Boye, et al.
Current Medical Research and Opinion|March 16, 2010
Elicitation of health state utilities in metastatic renal cell carcinomaPaul Swinburn, Andrew Lloyd, Paul Nathan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 27, 2012
Elicitation of health state utilities in soft tissue sarcomaSarah L Shingler, Paul Swinburn, Andrew Lloyd, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 18, 2010
A valuation of infusion therapy to preserve islet function in type 1 diabetesAndrew Lloyd, Paul Swinburn, Kristina S Boye, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 28, 2012
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyM F Janssen, A Simon Pickard, Dominik Golicki, et al.
Pageof 2